Therefore, we examined changes in AKT, GSK3β, NeuN, BDNF, and GFAP expression in a rat model, and our data showed that AKT and downstream GSK3β expression was reduced in the brains of rats with HFD/STZ-induced hyperglycemia. The gene discussed is AKT1; the disease is Hyperglycemia.